St Jude Medical buys up Epicor stocks
This article was originally published in Clinica
Executive Summary
St Jude Medical has acquired Epicor Medical in a $185m cash transaction, having previously made a $15m investment in the developer of an epicardial ablation system for treatment of atrial fibrillation (AF). St Jude had taken a minority stake in Epicor in May 2003 (see Clinica No 1056, p 17) and under the agreement, it reserved the right to buy the Sunnyvale, California-based company outright in 2004 providing certain clinical and regulatory milestones were met.